A Decentralized, Randomized Phase 2 Efficacy and Safety Study of Nirmatrelvir/Ritonavir in Adults with Long COVID.
Clinical trial NCT05668091 · COMPLETED
Trial details
- NCT number
- NCT05668091
- Sponsor
- Harlan M Krumholz
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-14
- Primary completion
- 2024-04-09
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.